Frequent cystoscopy for monitoring nonmuscle-invasive bladder cancer (NMIBC) is burdensome and costly, prompting a search for alternatives.

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.